GlassScriptPhysician profile
Ravin Manu Rupani
NPI 1730379728
$26,556.27
in general payments reported to CMS, 2019-2025
80 companies · $3,713 in 2025
The $3,713 reported for 2025 was more than what 78% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,622 · 2020: $3,128 · 2021: $3,927 · 2022: $4,416 · 2023: $4,979 · 2024: $3,770 · 2025: $3,713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,030.64 |
| Education | $432.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $2,403.72 | 2019-2025 | Reblozyl, Opdualag, Pomalyst |
| Novartis Pharmaceuticals Corporation | $2,070.82 | 2019-2025 | |
| Pfizer INC. | $1,392.31 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,322.53 | 2019-2025 | Opdivo |
| Incyte Corporation | $1,260.01 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Astrazeneca Pharmaceuticals LP | $1,091.70 | 2019-2025 | Tagrisso, Calquence, Enhertu |
| Merck Sharp & Dohme LLC | $1,048.83 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Astellas Pharma US INC | $1,012.13 | 2019-2025 | Padcev, Xospata, Xtandi |
| Janssen Biotech, INC. | $951.44 | 2019-2025 | Erleada, Imbruvica, Darzalex |
| Glaxosmithkline, LLC. | $912.39 | 2020-2025 | Zejula, Jemperli, Ojjaara |
| Takeda Pharmaceuticals U.S.A., INC. | $776.11 | 2019-2025 | Ninlaro, Iclusig, Fruzaqla |
| Seagen INC. | $703.57 | 2019-2025 | Adcetris, Tukysa |
| Eisai INC. | $694.04 | 2019-2025 | |
| Genzyme Corporation | $687.57 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $640.41 | 2019-2025 |
Show all 80 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $604.19 | 2019-2025 | Polivy, Phesgo, Venclexta |
| Pharmacyclics LLC, An Abbvie Company | $575.10 | 2019-2023 | Imbruvica, Epkinly |
| Daiichi Sankyo INC. | $497.70 | 2020-2025 | Enhertu, Datroway |
| Gilead Sciences, INC. | $477.94 | 2019-2025 | Trodelvy |
| Amgen INC. | $447.01 | 2019-2023 | Lumakras |
| Exelixis INC. | $445.02 | 2019-2025 | Cabometyx |
| Lilly USA, LLC | $444.82 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Kite Pharma, INC. | $363.97 | 2020-2025 | Yescarta |
| Abbvie INC. | $354.21 | 2019-2025 | Venclexta |
| Array Biopharma INC | $326.92 | 2019-2025 | Braftovi, Mektovi, Lorbrena |
| Taiho Oncology, INC. | $313.79 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $312.13 | 2019-2025 | Gilotrif |
| Rigel Pharmaceuticals, INC. | $298.72 | 2019-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Karyopharm Therapeutics INC. | $293.93 | 2020-2024 | Xpovio |
| Emd Serono, INC. | $270.76 | 2019-2025 | Bavencio |
| Puma Biotechnology, INC. | $268.46 | 2019-2024 | Nerlynx |
| Beigene USA, INC. | $174.09 | 2022-2025 | Brukinsa |
| Regeneron Healthcare Solutions, INC. | $172.78 | 2020-2024 | Libtayo |
| Pharmaessentia USA Corporation | $168.18 | 2023-2025 | Besremi |
| Sobi, INC | $167.44 | 2022-2025 | |
| Tersera Therapeutics LLC | $150.56 | 2019-2023 | Xermelo |
| Alexion Pharmaceuticals, INC. | $131.28 | 2019-2024 | Ultomiris |
| Adaptive Biotechnologies Corporation | $116.11 | 2023-2025 | Clonoseq |
| Blueprint Medicines Corporation | $101.76 | 2020-2023 | Ayvakit |
| Adc Therapeutics America, INC. | $99.49 | 2023-2025 | |
| Genmab U.S., INC. | $98.79 | 2023-2024 | Epkinly |
| Stemline Therapeutics INC. | $97.94 | 2023-2025 | Orserdu, Elzonris |
| Dendreon Pharmaceuticals LLC | $93.26 | 2020-2022 | |
| Springworks Therapeutics, INC. | $90.88 | 2024-2025 | Ogsiveo |
| Secura Bio, INC. | $87.53 | 2019-2021 | |
| Mirati Therapeutics, INC. | $87.49 | 2023-2024 | Krazati |
| Deciphera Pharmaceuticals INC. | $85.97 | 2021-2025 | Qinlock, Tgct |
| Morphosys, US INC. | $79.40 | 2022-2024 | Monjuvi |
| Epizyme, INC. | $76.13 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $73.00 | 2023-2025 | Orgovyx |
| Myovant Sciences INC. | $72.54 | 2021-2022 | |
| Dova Pharmaceuticals | $71.36 | 2020-2021 | |
| Verastem, INC. | $70.44 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $69.64 | 2020-2021 | |
| G1 Therapeutics, INC. | $67.09 | 2022-2023 | Cosela |
| Syndax Pharmaceuticals, INC. | $60.30 | 2025 | |
| Ge Healthcare | $54.28 | 2021-2022 | |
| Aveo Pharmaceuticals, INC. | $51.39 | 2023-2024 | Fotivda |
| Clovis Oncology, INC. | $48.32 | 2020 | |
| Recordati_rare_diseases_inc. | $44.86 | 2023 | Sylvant |
| Eusa Pharma (US) LLC | $43.92 | 2019-2020 | |
| Global Blood Therapeutics, INC. | $42.88 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $42.19 | 2019 | |
| Agios Pharmaceuticals, INC. | $37.07 | 2020 | |
| Emmaus Medical, INC. | $34.05 | 2020-2023 | Endari |
| Immunocore Limited | $34.05 | 2024 | Kimmtrak |
| Foundation Medicine, INC. | $30.95 | 2021 | |
| Janssen Scientific Affairs, LLC | $29.29 | 2019 | |
| Iovance Biotherapeutics, INC. | $27.61 | 2025 | Amtagvi |
| Beone Medicines USA, INC. | $27.20 | 2025 | Brukinsa |
| Sun Pharmaceutical Industries INC. | $25.50 | 2023 | Yonsa, Odomzo |
| Acrotech Biopharma INC. | $22.47 | 2021 | |
| Coherus Oncology, INC. | $21.90 | 2025 | Loqtorzi |
| Immunogen, INC. | $20.78 | 2024 | Elahere |
| Mylan Institutional INC. | $16.99 | 2022 | |
| Tesaro, INC. | $16.65 | 2019 | |
| Telix Pharmaceuticals | $15.69 | 2025 | Illuccix |
| Partner Therapeutics, INC. | $14.38 | 2019 | |
| Advanced Accelerator Applications | $14.09 | 2020 | |
| Sirtex Medical INC | $14.06 | 2020 |
Drugs and devices associated with these payments
Kisqali $762Reblozyl $718Keytruda $584Imbruvica $508Enhertu $416Lenvima $404Zejula $375Jemperli $360Epkinly $327Jakafi $319Lynparza $274Adcetris $224Orgovyx $220Monjuvi $219Xtandi $210Erleada $204Padcev $198Braftovi $196Opdivo $194Elrexfio $192Brukinsa $183Nubeqa $181Tagrisso $172Besremi $168Bosulif $168Calquence $167Ninlaro $158Mektovi $156Fabhalta $150Scemblix $148Talzenna $146Lonsurf $141Inqovi $141Cabometyx $131Venclexta $131Ojjaara $125Iclusig $124Tukysa $122Lorbrena $117Xpovio $117Clonoseq $116Verzenio $115Polivy $115Rezlidhia $114Tavalisse $114Libtayo $107Stivarga $106Yescarta $106Fruzaqla $98.36Elahere $97.00Trodelvy $94.18Phesgo $92.49Ogsiveo $90.88Inlyta $90.67Krazati $87.49Ultomiris $85.67Opdualag $81.25Enjaymo $80.31Cablivi $80.31Xospata $78.78Gilotrif $77.54Jaypirca $72.71Orserdu $71.69Welireg $71.33Pemazyre $70.83Zynlonta $70.45Doptelet $64.49Promacta $61.53Vitrakvi $59.36Imfinzi $58.39Zynyz $56.44Ibrance $55.12Datroway $54.97Alunbrig $53.78Fotivda $51.39Besponsa $51.10Wayrilz $49.15Sarclisa $48.78Qinlock $45.17Sylvant $44.86Darzalex $44.47Retevmo $43.52Rybrevant $41.61Gavreto $40.03Tivdak $39.70Vonjo $37.89Xermelo $35.71Keytruda Qlex $34.71Kimmtrak $34.05Vyloy $33.69Akeega $32.81Balversa $32.81Illuccix $31.38Perjeta $29.16Mekinist $27.92Amtagvi $27.61Nerlynx $26.80Tecvayli $26.31Elzonris $26.25Xalkori $25.96
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravin Rupani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.